Transfer of Low-Molecular Weight Single-Stranded DNA through the Membrane of a High-Flux Dialyzer

Author:

Tao Xia1,Hoenich Nicholas2,Handelman Samuel K.3,Levin Nathan W.4,Kotanko Peter4,Handelman Garry J.1

Affiliation:

1. Department of Clinical Laboratory and Nutritional Sciences, University of Massachusetts, Lowell, MA - USA

2. Institute of Cellular Medicine, Newcastle University, Newcastle-on-Tyne - UK

3. Department of Pharmacology, Ohio State University, Columbus, Ohio - USA

4. Renal Research Institute, New York, NY - USA

Abstract

Purpose Microbial contamination is often present in dialysate used for hemodialysis. Small single-stranded bacterial DNA sequences are capable of activating human inflammatory pathways, through mechanisms that include the Toll-like-receptor 9, and dialysis patients frequently show severe inflammation. Since these molecules have been found in dialysate and in patients’ bloodstreams, we studied the potential of low-molecular weight DNA sequences, of the same structure as found in bacteria, to cross from the dialyzer circuit to the blood circuit of a dialysis filter. Methods The mass transfer of DNA fragments across a high-flux dialyzer was evaluated with an in vitro dialysis model, in both conventional dialysis and pure convection mode. Measurement of DNA was performed by HPLC. Results In dialysis mode, these mass transfer coefficients were calculated for different single-stranded DNA chain lengths: 5-bases = 28.5%, 9-bases = 20.5%, 20-bases = 9.4%, 35-bases = 2.4%, 50-bases and 100-bases, no transfer detected. In convection mode, these sieving coefficients were calculated: 5-bases = 1.0, 9-bases = 1.0, 20-bases = 0.68, 35-bases = 0.40, 50-bases = 0.17, 100-bases, no convective transfer detected. The physical size of DNA molecules could be the major factor that influences their movement through dialyzer pores. Conclusions This study establishes that significant transfer across the dialyzer may occur with singlestranded DNA in the size range of 20-bases or less. These findings need to be confirmed with an in vitro whole blood model and with clinical investigations. Previous studies have described the clinical benefits of achieving high-purity dialysate. Precautions are warranted to minimize the presence of these DNA compounds in fluids utilized for hemodialysis treatment.

Publisher

SAGE Publications

Subject

Biomedical Engineering,Biomaterials,General Medicine,Medicine (miscellaneous),Bioengineering

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Ultrapure dialysis fluid for hemodialysis and related therapies;AAMI TIR43:2021; Ultrapure dialysis fluid for hemodialysis and related therapies;2021-02-26

2. Guidance for the preparation and quality management of fluids for haemodialysis and related therapies—Part 3: Water for haemodialysis and related therapies;ANSI/AAMI/ISO 23500-3:2019; Preparation and quality management of fluids for haemodialysis and related therapies—Part 3: Water for haemodialysis and related therapies;2019-12-23

3. Effects of Hemodiafiltration of Inflammation and Oxidative Stress;Hemodiafiltration;2015-11-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3